Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily Blumberg

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 13, 2005
Determinants of transplant surgeons' willingness to provide organs to patients infected with HBV, HCV or HIVScott D Halpern, David A Asch, Abraham Shaked, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 30, 2025
Letermovir should be first-line cytomegalovirus prophylaxis in lung transplant recipientsAlyssa K Mezochow, Emily Clausen, Kathryn Whitaker, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 27, 2025
Impact of Donor Radiographic Pneumonia on Posttransplant Recipient Outcomes and MicrobiologyKevin D He, Susanna M Leonard, Alyssa Mezochow, et al.
JHLT Open|March 27, 2025
Letermovir use for cytomegalovirus prophylaxis following lung transplantation: A single-center reviewAlyssa K Mezochow, Kevin D He, Kathryn Whitaker, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 9, 2021
Antibodies, boosters, and optimizing SARS-CoV-2 vaccines for transplantation: A call for more researchMichael G Ison, Emily Blumberg, Natasha Halasa, et al.
Transplantation|April 28, 2006
24-week oral ganciclovir prophylaxis in kidney recipients is associated with reduced symptomatic cytomegalovirus disease compared to a 12-week courseAlden M Doyle, Karen M Warburton, Simin Goral, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 28, 2023
Age-related decline in anti-HBV antibodies in vaccinated kidney transplant recipientsDarshana M Dadhania, Paolo Cravedi, Emily Blumberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 18, 2015
Beyond the NIH Multicenter HIV Transplant Trial Experience: Outcomes of HIV+ Liver Transplant Recipients Compared to HCV+ or HIV+/HCV+ Coinfected Recipients in the United StatesDeirdre Sawinski, David S Goldberg, Emily Blumberg, et al.
Journal of the Pediatric Infectious Diseases Society|September 4, 2015
Screening and Monitoring for Infectious Complications When Immunosuppressive Agents Are Studied in the Treatment of Autoimmune DisordersBrett J Loechelt, Michael Green, Peter A Gottlieb, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 3, 2013
Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of TransplantationMichael R Lucey, Norah Terrault, Lolu Ojo, et al.
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 13, 2005
Determinants of transplant surgeons' willingness to provide organs to patients infected with HBV, HCV or HIVScott D Halpern, David A Asch, Abraham Shaked, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 30, 2025
Letermovir should be first-line cytomegalovirus prophylaxis in lung transplant recipientsAlyssa K Mezochow, Emily Clausen, Kathryn Whitaker, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 27, 2025
Impact of Donor Radiographic Pneumonia on Posttransplant Recipient Outcomes and MicrobiologyKevin D He, Susanna M Leonard, Alyssa Mezochow, et al.
JHLT Open|March 27, 2025
Letermovir use for cytomegalovirus prophylaxis following lung transplantation: A single-center reviewAlyssa K Mezochow, Kevin D He, Kathryn Whitaker, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 9, 2021
Antibodies, boosters, and optimizing SARS-CoV-2 vaccines for transplantation: A call for more researchMichael G Ison, Emily Blumberg, Natasha Halasa, et al.
Transplantation|April 28, 2006
24-week oral ganciclovir prophylaxis in kidney recipients is associated with reduced symptomatic cytomegalovirus disease compared to a 12-week courseAlden M Doyle, Karen M Warburton, Simin Goral, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 28, 2023
Age-related decline in anti-HBV antibodies in vaccinated kidney transplant recipientsDarshana M Dadhania, Paolo Cravedi, Emily Blumberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 18, 2015
Beyond the NIH Multicenter HIV Transplant Trial Experience: Outcomes of HIV+ Liver Transplant Recipients Compared to HCV+ or HIV+/HCV+ Coinfected Recipients in the United StatesDeirdre Sawinski, David S Goldberg, Emily Blumberg, et al.
Journal of the Pediatric Infectious Diseases Society|September 4, 2015
Screening and Monitoring for Infectious Complications When Immunosuppressive Agents Are Studied in the Treatment of Autoimmune DisordersBrett J Loechelt, Michael Green, Peter A Gottlieb, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 3, 2013
Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of TransplantationMichael R Lucey, Norah Terrault, Lolu Ojo, et al.
Pageof 7